TITLE:
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

CONDITION:
Asthma

INTERVENTION:
anti-IL-4 monoclonal antibody (pascolizumab)

SUMMARY:

      The purpose of the study is to evaluate an investigational medication to treat chronic
      asthma. The research is being conducted at 20 clinical research sites in the US and is open
      to both men and women ages 18 to 70 years. Participants in the study will have a number of
      visits to a research site over an 8-month period. All study-related care and medication is
      provided to qualified participants at no cost. This includes all visits, examinations and
      laboratory work.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  At least a 6-month history of asthma

          -  No use of inhaled, oral or injectable steroids for at least 1 month prior to
             enrollment

        Exclusion Criteria:

          -  Patients with > 10 pack years of smoking history or smoking within 12 months of study
             enrollment

          -  No significant disease other than asthma
      
